These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 36332476)

  • 21. TREM2 protects against inflammation by regulating the release of mito-DAMPs from hepatocytes during liver fibrosis.
    Shan S; Chao S; Liu Z; Wang S; Liu Z; Zhang C; Cheng D; Su Z; Song F
    Free Radic Biol Med; 2024 Aug; 220():154-165. PubMed ID: 38710340
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Listeria-based hepatocellular carcinoma vaccine facilitates anti-PD-1 therapy by regulating macrophage polarization.
    Xu G; Feng D; Yao Y; Li P; Sun H; Yang H; Li C; Jiang R; Sun B; Chen Y
    Oncogene; 2020 Feb; 39(7):1429-1444. PubMed ID: 31659256
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triggering receptor expressed on myeloid cells-2 expression in the brain is required for maximal phagocytic activity and improved neurological outcomes following experimental stroke.
    Kurisu K; Zheng Z; Kim JY; Shi J; Kanoke A; Liu J; Hsieh CL; Yenari MA
    J Cereb Blood Flow Metab; 2019 Oct; 39(10):1906-1918. PubMed ID: 30523715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myeloid Trem2 ameliorates the progression of metabolic dysfunction-associated steatotic liver disease by regulating macrophage pyroptosis and inflammation resolution.
    Yu W; Zhang Y; Sun L; Huang W; Li X; Xia N; Chen X; Wikana LP; Xiao Y; Chen M; Han S; Wang Z; Pu L
    Metabolism; 2024 Jun; 155():155911. PubMed ID: 38609037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Triggering receptor expressed on myeloid Cells-2 (TREM2) inhibits steroidogenesis in adrenocortical cell by macrophage-derived exosomes in lipopolysaccharide-induced septic shock.
    Ye H; Zhai Q; Fang P; Yang S; Sun Y; Wu S; Huang R; Chen Q; Fang X
    Mol Cell Endocrinol; 2021 Apr; 525():111178. PubMed ID: 33556472
    [TBL] [Abstract][Full Text] [Related]  

  • 26.
    Yu M; Chang Y; Zhai Y; Pang B; Wang P; Li G; Jiang T; Zeng F
    Front Immunol; 2022; 13():1089266. PubMed ID: 36713360
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-PD-1/PD-L1 Blockade Immunotherapy Employed in Treating Hepatitis B Virus Infection-Related Advanced Hepatocellular Carcinoma: A Literature Review.
    Li B; Yan C; Zhu J; Chen X; Fu Q; Zhang H; Tong Z; Liu L; Zheng Y; Zhao P; Jiang W; Fang W
    Front Immunol; 2020; 11():1037. PubMed ID: 32547550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High-salt diet downregulates TREM2 expression and blunts efferocytosis of macrophages after acute ischemic stroke.
    Hu M; Lin Y; Men X; Wang S; Sun X; Zhu Q; Lu D; Liu S; Zhang B; Cai W; Lu Z
    J Neuroinflammation; 2021 Apr; 18(1):90. PubMed ID: 33845849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation.
    Chen X; Gao A; Zhang F; Yang Z; Wang S; Fang Y; Li J; Wang J; Shi W; Wang L; Zheng Y; Sun Y
    Theranostics; 2021; 11(7):3392-3416. PubMed ID: 33537094
    [No Abstract]   [Full Text] [Related]  

  • 30. Geniposide Enhances Macrophage Autophagy through Downregulation of TREM2 in Atherosclerosis.
    Xu YL; Liu XY; Cheng SB; He PK; Hong MK; Chen YY; Zhou FH; Jia YH
    Am J Chin Med; 2020; 48(8):1821-1840. PubMed ID: 33308094
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TREM2 Promotes Immune Evasion by Mycobacterium tuberculosis in Human Macrophages.
    Dabla A; Liang YC; Rajabalee N; Irwin C; Moonen CGJ; Willis JV; Berton S; Sun J
    mBio; 2022 Aug; 13(4):e0145622. PubMed ID: 35924849
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting tumor associated macrophages in hepatocellular carcinoma.
    Xu W; Cheng Y; Guo Y; Yao W; Qian H
    Biochem Pharmacol; 2022 May; 199():114990. PubMed ID: 35288152
    [TBL] [Abstract][Full Text] [Related]  

  • 33. TREM2 is a receptor for non-glycosylated mycolic acids of mycobacteria that limits anti-mycobacterial macrophage activation.
    Iizasa E; Chuma Y; Uematsu T; Kubota M; Kawaguchi H; Umemura M; Toyonaga K; Kiyohara H; Yano I; Colonna M; Sugita M; Matsuzaki G; Yamasaki S; Yoshida H; Hara H
    Nat Commun; 2021 Apr; 12(1):2299. PubMed ID: 33863908
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adrenal gland macrophages regulate glucocorticoid production through Trem2 and TGF-β.
    Xu Y; Patterson MT; Dolfi B; Zhu A; Bertola A; Schrank PR; Gallerand A; Kennedy AE; Hillman H; Dinh L; Shekhar S; Tollison S; Bold TD; Ivanov S; Williams JW
    JCI Insight; 2024 Jun; 9(14):. PubMed ID: 38869957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CXCR4 inhibition in tumor microenvironment facilitates anti-programmed death receptor-1 immunotherapy in sorafenib-treated hepatocellular carcinoma in mice.
    Chen Y; Ramjiawan RR; Reiberger T; Ng MR; Hato T; Huang Y; Ochiai H; Kitahara S; Unan EC; Reddy TP; Fan C; Huang P; Bardeesy N; Zhu AX; Jain RK; Duda DG
    Hepatology; 2015 May; 61(5):1591-602. PubMed ID: 25529917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triggering Receptors Expressed on Myeloid Cells 2 Promotes Corneal Resistance Against
    Qu W; Wang Y; Wu Y; Liu Y; Chen K; Liu X; Zou Z; Huang X; Wu M
    Front Immunol; 2018; 9():1121. PubMed ID: 29887864
    [TBL] [Abstract][Full Text] [Related]  

  • 37. TREM2: Keeping Pace With Immune Checkpoint Inhibitors in Cancer Immunotherapy.
    Qiu H; Shao Z; Wen X; Jiang J; Ma Q; Wang Y; Huang L; Ding X; Zhang L
    Front Immunol; 2021; 12():716710. PubMed ID: 34539652
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TREM2 expression promotes liver and peritoneal M2 macrophage polarization in mice infected with Schistosoma japonicum.
    Zhu D; Huang M; Shen P; Zhang B; Chen G; Chen J; Duan L; Duan Y
    J Cell Mol Med; 2023 Aug; 27(15):2261-2269. PubMed ID: 37430471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Soluble TREM2 levels reflect the recruitment and expansion of TREM2
    Hendrikx T; Porsch F; Kiss MG; Rajcic D; Papac-Miličević N; Hoebinger C; Goederle L; Hladik A; Shaw LE; Horstmann H; Knapp S; Derdak S; Bilban M; Heintz L; Krawczyk M; Paternostro R; Trauner M; Farlik M; Wolf D; Binder CJ
    J Hepatol; 2022 Nov; 77(5):1373-1385. PubMed ID: 35750138
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Systematic Pan-Cancer Analysis Identifies TREM2 as an Immunological and Prognostic Biomarker.
    Cheng X; Wang X; Nie K; Cheng L; Zhang Z; Hu Y; Peng W
    Front Immunol; 2021; 12():646523. PubMed ID: 33679809
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.